CytoDyn Inc. (CYDY)
Develops an antibody drug candidate to treat cancer and infectious diseases.
$0.20-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-32.8%
The outlook
CYDY trades near the lower end of its 52-week range and sits below both its 50- and 200-day moving averages, reflecting a downtrend. Analyst coverage appears minimal based on available data. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$267.1M
52-wk high
$0.40
52-wk low
$0.19
50-day avg
$0.27
200-day avg
$0.28
Trailing P/E
—